Cannara Biotech Inc Cash Flow Reinvestment Rate
Cannara Biotech Inc cash flow reinvestment rate. Cannara Biotech Inc (LOVE) has a Cash Flow Reinvestment Rate of 0.58x as of November 2025, reinvesting CA$4.62 Million (capex CA$4.62 Million ) from operating cash flow of CA$7.96 Million. See LOVE FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Cannara Biotech Inc (2023–2025)
Cash flow reinvestment rate of Cannara Biotech Inc from 2023 to 2025. Historical reinvestment intensity for Cannara Biotech Inc across 3 annual periods. Explore cash flow to debt ratio of Cannara Biotech Inc to assess how comfortably operating cash covers total debt obligations.
Cannara Biotech Inc Cash Flow Reinvestment Rate by Year (2023–2025)
Cannara Biotech Inc cash flow reinvestment rate by year from 2023 to 2025. Year-by-year capital reinvestment analysis for Cannara Biotech Inc. For the full cash flow conversion analysis, see Cannara Biotech Inc operating cash flow efficiency.
| Year | Reinvestment Rate | Total Reinvested (CAD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.62x | CA$12.31 Million | CA$20.01 Million | CA$6.36 Million | ▼ -48.1% |
| 2024 | 1.18x | CA$12.66 Million | CA$10.68 Million | CA$7.47 Million | ▼ -63.8% |
| 2023 | 3.27x | CA$19.36 Million | CA$5.91 Million | CA$9.88 Million | — |